Quantum-Si (NASDAQ:QSI – Get Free Report) was upgraded by equities research analysts at Wall Street Zen from a “sell” rating to a “hold” rating in a report issued on Saturday, Wall Street Zen reports.
A number of other research firms have also recently weighed in on QSI. Weiss Ratings cut shares of Quantum-Si from a “sell (d-)” rating to a “sell (e+)” rating in a report on Wednesday. Alliance Global Partners reiterated a “buy” rating on shares of Quantum-Si in a research note on Friday, August 14th. One analyst has rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $1.00.
Get Our Latest Stock Analysis on Quantum-Si
Quantum-Si Stock Performance
Quantum-Si (NASDAQ:QSI – Get Free Report) last issued its quarterly earnings data on Thursday, August 13th. The company reported ($0.11) earnings per share for the quarter, meeting analysts’ consensus estimates of ($0.11). Quantum-Si had a negative return on equity of 47.12% and a negative net margin of 6,138.26%.The company had revenue of $0.34 million for the quarter, compared to the consensus estimate of $0.30 million. On average, equities research analysts forecast that Quantum-Si will post -0.47 EPS for the current year.
Institutional Investors Weigh In On Quantum-Si
Large investors have recently modified their holdings of the business. Prudential Financial Inc. acquired a new position in shares of Quantum-Si during the second quarter valued at about $25,000. IPG Investment Advisors LLC acquired a new stake in Quantum-Si in the 2nd quarter worth approximately $27,000. Leonteq Securities AG purchased a new stake in Quantum-Si during the 4th quarter worth approximately $28,000. Cerity Partners LLC purchased a new stake in Quantum-Si during the 2nd quarter worth approximately $29,000. Finally, Hollencrest Capital Management increased its stake in Quantum-Si by 301.1% during the 1st quarter. Hollencrest Capital Management now owns 40,111 shares of the company’s stock valued at $31,000 after purchasing an additional 30,111 shares in the last quarter. Hedge funds and other institutional investors own 39.90% of the company’s stock.
About Quantum-Si
Quantum-Si Inc is a life sciences instrumentation company headquartered in Guilford, Connecticut, developing next-generation proteomics solutions based on semiconductor sequencing technology. The company’s core offering centers on a proprietary single-molecule protein sequencing platform that uses a silicon-based sensor chip to convert protein data into digital signals. This approach is designed to deliver high sensitivity, single-amino-acid resolution and deep proteome coverage while potentially reducing cost and complexity compared to traditional mass spectrometry methods.
Quantum-Si’s product roadmap includes the development and commercialization of an integrated system comprising instruments, consumable reagents and proprietary data analysis software.
Read More
- Five stocks we like better than Quantum-Si
- Why Bitcoin ETFs May Be Worth Another Look as Inflows Rebound
- 3 Small-Cap Biotechs With Binary Catalysts on the Calendar
- Planet Labs Has Fallen Back to Earth, But Wall Street Still Sees a Rebound
- As Homeowners’ Premiums Surge, This Insurer Is Posting Record Profits
Receive News & Ratings for Quantum-Si Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quantum-Si and related companies with MarketBeat.com's FREE daily email newsletter.
